N-hydroxy-2-(3'-benzyl-2',5'-dioxo-6,7,8,9-tetrahydrospiro[benzo[7]annulene-5,4'-imidazolidin]-1'-yl)acetamide

ID: ALA4475849

PubChem CID: 155537935

Max Phase: Preclinical

Molecular Formula: C22H23N3O4

Molecular Weight: 393.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)N(Cc2ccccc2)C2(CCCCc3ccccc32)C1=O)NO

Standard InChI:  InChI=1S/C22H23N3O4/c26-19(23-29)15-24-20(27)22(13-7-6-11-17-10-4-5-12-18(17)22)25(21(24)28)14-16-8-2-1-3-9-16/h1-5,8-10,12,29H,6-7,11,13-15H2,(H,23,26)

Standard InChI Key:  JGZSTJKMFWQYDD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   23.1322  -17.5316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7236  -18.7904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5408  -18.7904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7952  -18.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4735  -18.0137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2425  -19.4509    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.5727  -17.7622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2425  -19.1990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9517  -18.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6579  -19.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.9547  -17.9758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6549  -20.0214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7133  -15.7364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5296  -15.7354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0451  -16.3756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8696  -17.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3899  -17.1809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2049  -16.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4224  -16.1448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8241  -16.7048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0137  -17.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7959  -17.7392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6556  -18.0112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2448  -18.7177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4273  -18.7105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0167  -19.4161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4232  -20.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2446  -20.1259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6516  -19.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  1  1  0
  1  5  1  0
  5  2  1  0
  2  6  2  0
  4  7  2  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 13 14  1  0
 14 15  1  0
 13 18  1  0
 15 16  1  0
 16  1  1  0
 17  1  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  5 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475849

    ---

Associated Targets(Human)

Huh-5-2 (386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L6 (7924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.44Molecular Weight (Monoisotopic): 393.1689AlogP: 2.58#Rotatable Bonds: 4
Polar Surface Area: 89.95Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.75CX Basic pKa: CX LogP: 2.78CX LogD: 2.76
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.55

References

1. Giannakopoulou E, Pardali V, Frakolaki E, Siozos V, Myrianthopoulos V, Mikros E, Taylor MC, Kelly JM, Vassilaki N, Zoidis G..  (2019)  Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.,  10  (6): [PMID:31303998] [10.1039/C9MD00200F]

Source